Actemra SC — Medical Mutual
Giant Cell Arteritis (GCA)
Initial criteria
- Patient has tried one systemic corticosteroid (e.g., prednisone); AND
- Medication is prescribed by or in consultation with a rheumatologist; AND
- Site of care medical necessity is met
Reauthorization criteria
- Patient has been established on therapy for at least 6 months; AND
- Patient experienced a beneficial clinical response from baseline assessed by objective measures OR patient experienced an improvement in at least one symptom compared with baseline
Approval duration
initial: 6 months; reauth: 1 year